Oncotarget Overcoming Aromatase Inhibitor Resistance in Breast Cancer: A New Therapeutic Strategy The estrogen receptor is overexpressed in and promotes 67-80% and 90% of female and male... read more January 13, 2026
Oncotarget Exploring a Combined Approach: Radiation and Immunotherapy in Bladder Cancer Different treatment strategies are required for the non-muscle-invasive, muscle-invasive, and metastatic stages of bladder cancer."... read more June 16, 2025
Oncotarget Combining Regorafenib and TAS102 to Target Gastrointestinal Cancers and Overcome Cancer Stemness In this research paper, researchers demonstrate a promising new treatment option for refractory metastatic gastrointestinal... read more August 9, 2024
Oncotarget Novel Triple-Drug Combination to Fight Pancreatic Cancer In this new study, researchers unveiled a promising synergistic strategy for combating pancreatic cancer.—In... read more July 25, 2024
Oncotarget AI for Improved PET/CT Attenuation Correction in Prostate Cancer Imaging In this new study, researchers investigated an artificial intelligence (AI) tool that produces attenuation-corrected PET... read more July 11, 2024
Oncotarget Impact of Dual Immunotherapies Before Surgery in HR+/HER2-negative Breast Cancer In this new study, researchers assessed the feasibility of treating HR+/HER2-negative breast cancer patients... read more June 20, 2024
Oncotarget Dr. Blagosklonny’s Strategy: From Osimertinib to Preemptive Combinations This article dissects Dr. Mikhail V. Blagosklonny’s paradigm-shifting perspective on preemptive combinations for treating... read more June 6, 2024
Oncotarget Combating Doxorubicin-Resistant Acute Myeloid Leukemia In this new study, researchers examined the impact of MIA-602 as monotherapy and in combination... read more May 23, 2024
Oncotarget SARS-CoV-2 Spike Protein Disrupts p53 Tumor Suppressor Pathway In this new study, researchers investigated the interplay between the SARS-CoV-2 spike protein and tumor... read more May 9, 2024
Oncotarget Synergistic Effects of Drug Combinations Targeting AML Cells In this new study, researchers investigated a promising new approach to acute myeloid leukemia (AML)... read more April 11, 2024